Loading clinical trials...
Loading clinical trials...
Myelomeningocele is a malformation of the spine and spinal cord, generally diagnosed prenatally, and responsible for a complex disability for the unborn child. In the event of continued pregnancy, in utero surgery can be performed to improve the prognosis of the children. This fetal therapy does not allow a cure and induces risks for the fetus, and for the mother, both during surgery and for her obstetric future. Currently, few studies have focused on the factors influencing the choice to resort to in utero surgery and the experience of patients and co-parents before and after this intervention. No qualitative study on the subject has been published to date.
The study population corresponds to all couples who have chosen to continue the pregnancy in the face of a prenatal diagnosis of myelomeningocele in their fetus as well as to resort to in utero surgery to repair this malformation. In order to obtain the largest possible sample, the study will be offered to both couples who have had open surgery and those who have had fetoscopy. This study aims to investigate, a posteriori, the experience of couples who have chosen fetal surgery to repair a myelomeningocele. This is a study in clinical psychology, cross-sectional observational with an approach that will be mixed, qualitative and quantitative. In practice, the only procedures added by the research will consist of: * an interview between the mother of the child operated on in utero and a psychologist researcher-student pair in Master 2 of psychology * an interview between the father of the child operated on in utero and a psychologist researcher-student pair in Master 2 of psychology * the completion of a decision scale by each of the parents The presence of the interview with a psychologist not planned as part of the care may lead to the modification of the usual care of the parents.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
Yes
Service de Médecine Foetale Hôpital Armand Trousseau
Paris, Paris, France
Start Date
September 23, 2024
Primary Completion Date
March 1, 2026
Completion Date
March 1, 2026
Last Updated
January 28, 2025
44
ESTIMATED participants
Semi-structured interviews with a psychologist
OTHER
Lead Sponsor
Assistance Publique - Hôpitaux de Paris
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions